City Therapeutics Shares Rise 25% in Trading Debut After $200 Million IPO
Shares recently traded at $22.53 after opening at $23, following the company's upsized IPO that raised about $200 million.
By Colin KellaherShares of City Therapeutics rose sharply in their trading debut Friday after the clinical-stage biotechnology's upsized initial public offering raised about $200 million.City shares were recently changing hands at $22.53, up 25%, after opening at $23.The Cambridge, Mass., company l…